These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21393831)

  • 1. Structure of the extended-spectrum β-lactamase TEM-72 inhibited by citrate.
    Docquier JD; Benvenuti M; Calderone V; Rossolini GM; Mangani S
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Mar; 67(Pt 3):303-6. PubMed ID: 21393831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation the role of mutations M182T and Q39K in structure of beta-lactamase TEM-72 by molecular dynamics method].
    Shcherbinin DS; Rubtsova MY; Grigorenko VG; Uporov IV; Veselovsky AV; Egorov AM
    Biomed Khim; 2016 Jul; 62(5):527-534. PubMed ID: 27797327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
    Cantu C; Huang W; Palzkill T
    J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.
    Jones CH; Ruzin A; Tuckman M; Visalli MA; Petersen PJ; Bradford PA
    Antimicrob Agents Chemother; 2009 Mar; 53(3):977-86. PubMed ID: 19075050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of threonine-to-methionine substitution at position 265 on structure and function of TEM-1 beta-lactamase.
    Huang W; Le QQ; LaRocco M; Palzkill T
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2266-9. PubMed ID: 7840555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland.
    Baraniak A; Fiett J; Mrówka A; Walory J; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2005 May; 49(5):1872-80. PubMed ID: 15855509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
    Winkler ML; Bonomo RA
    Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime.
    Venkatachalam KV; Huang W; LaRocco M; Palzkill T
    J Biol Chem; 1994 Sep; 269(38):23444-50. PubMed ID: 8089110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the extended substrate spectrum of AmpC BER and structure-guided discovery of the inhibition activity of citrate against the class C β-lactamases AmpC BER and CMY-10.
    Na JH; Cha SS
    Acta Crystallogr D Struct Biol; 2016 Aug; 72(Pt 8):976-85. PubMed ID: 27487828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy.
    Perilli M; Segatore B; de Massis MR; Riccio ML; Bianchi C; Zollo A; Rossolini GM; Amicosante G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2537-9. PubMed ID: 10952610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
    Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
    J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of long-distance mutations on the Ω-loop conformation in TEM type β-lactamases.
    Shcherbinin D; Veselovsky A; Rubtsova M; Grigorenko V; Egorov A
    J Biomol Struct Dyn; 2020 May; 38(8):2369-2376. PubMed ID: 31241429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases.
    Petrosino J; Rudgers G; Gilbert H; Palzkill T
    J Biol Chem; 1999 Jan; 274(4):2394-400. PubMed ID: 9891008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.
    Brown NG; Pennington JM; Huang W; Ayvaz T; Palzkill T
    J Mol Biol; 2010 Dec; 404(5):832-46. PubMed ID: 20955714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors.
    Kalp M; Bethel CR; Bonomo RA; Carey PR
    Biochemistry; 2009 Oct; 48(41):9912-20. PubMed ID: 19736945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis.
    Cohen Stuart J; Dierikx C; Al Naiemi N; Karczmarek A; Van Hoek AH; Vos P; Fluit AC; Scharringa J; Duim B; Mevius D; Leverstein-Van Hall MA
    J Antimicrob Chemother; 2010 Jul; 65(7):1377-81. PubMed ID: 20462947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins.
    Raquet X; Vanhove M; Lamotte-Brasseur J; Goussard S; Courvalin P; Frère JM
    Proteins; 1995 Sep; 23(1):63-72. PubMed ID: 8539251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of residue 238 of TEM-1 beta-lactamase in the hydrolysis of extended-spectrum antibiotics.
    Cantu C; Palzkill T
    J Biol Chem; 1998 Oct; 273(41):26603-9. PubMed ID: 9756899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
    Stapleton PD; Shannon KP; French GL
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1881-7. PubMed ID: 10428907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.